Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Pharmacology›Hormesis
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Hormesis

Pharmacology · NLM MeSH · updated 2026-10-29 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 3 min read

Biphasic dose responses of cells or organisms (including microorganisms) to an exogenous or intrinsic factor, in which the factor induces stimulatory or beneficial effects at low doses and inhibitory or adverse effects at high dos

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (599 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

Biphasic dose responses of cells or organisms (including microorganisms) to an exogenous or intrinsic factor, in which the factor induces stimulatory or beneficial effects at low doses and inhibitory or adverse effects at high doses.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Hormeses; Hormetic Dose-Response; Dose-Response, Hormetic; Dose-Responses, Hormetic; Hormetic Dose Response; Hormetic Dose-Responses.

Where it fits in the MeSH classification

Broader topics
Dose-Response Relationship, Drug

Research landscape

PubMed indexes 962 records tagged with the MeSH heading “Hormesis” (counts retrieved 2026-10-29). 475 of them (49.4%) were published from 2020 onward, and the busiest period so far is 2010-2019 with 497 records.

Reviews account for 296 records (30.8%) and meta-analyses for 6. Randomized controlled trials number 2 (0.2%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 0 records; 2000-2009: 1 records; 2010-2019: 497 records; 2020 onward: 475 records0through 199912000-20094972010-20194752020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19990
2000-20091
2010-2019497
2020 onward475
Share of records by publication typeReviews: 30.8 percent; Meta-analyses: 0.6 percent; Randomized controlled trials: 0.2 percentReviews30.8% (296)Meta-analyses0.6% (6)Randomized controlled trials0.2% (2)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 962 PubMed records
TypeRecordsShare
Reviews29630.8%
Meta-analyses60.6%
Randomized controlled trials20.2%

Method: PubMed query "Hormesis"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.

Reading the evidence in pharmacology

Drug evidence builds in layers: laboratory pharmacology describes how a compound acts, pharmacokinetic studies describe how the body handles it, and randomized trials test whether it helps and what harms it causes. Post-marketing surveillance and observational studies reveal rarer adverse effects but cannot prove causation. This page is educational and is not a recommendation to start, stop or change any medicine; decisions about treatment belong with a qualified clinician.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Hormetic heat stress and HSF-1 induce autophagy to improve survival and proteostasis in C. elegans
Kumsta C, Chang JT, Schmalz J, Hansen M
2017Research article
Design not recorded in structured metadata
251cc by
PMID 28198373 · DOI · PMC5316864
Lithium Promotes Longevity through GSK3/NRF2-Dependent Hormesis
Castillo-Quan JI, Li L, Kinghorn KJ, Ivanov DK, Tain LS, Slack C, et al.
2016Research article
Design not recorded in structured metadata
160cc by
PMID 27068460 · DOI · PMC4850359
Hormesis: Path and Progression to Significance
Calabrese EJ
2018Review article
Design not recorded in structured metadata
158cc by
PMID 30248927 · DOI · PMC6213774
Moderate nutritional stress reprogrammes insulin responses to drive enhanced starvation tolerance in Drosophila melanogaster
Menon RV, Varghese J
2026Research article
Design not recorded in structured metadata
3cc by
PMID 41378461 · DOI · PMC12891944

Hormetic heat stress and HSF-1 induce autophagy to improve survival and proteostasis in C. elegans [1]

Research article Kumsta C, Chang JT, Schmalz J, Hansen M · · 2017 · cited 251 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Stress-response pathways have evolved to maintain cellular homeostasis and to ensure the survival of organisms under changing environmental conditions.
Closing excerpt
These findings demonstrate that autophagy contributes to stress resistance and hormesis, and reveal a requirement for autophagy in HSF-1-regulated functions in the heat-shock response, proteostasis and ageing.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (150 words)

Stress-response pathways have evolved to maintain cellular homeostasis and to ensure the survival of organisms under changing environmental conditions. Whereas severe stress is detrimental, mild stress can be beneficial for health and survival, known as hormesis. Although the universally conserved heat-shock response regulated by transcription factor HSF-1 has been implicated as an effector mechanism, the role and possible interplay with other cellular processes, such as autophagy, remains poorly understood. Here we show that autophagy is induced in multiple tissues of Caenorhabditis elegans following hormetic heat stress or HSF-1 overexpression. Autophagy-related genes are required for the thermoresistance and longevity of animals exposed to hormetic heat shock or HSF-1 overexpression. Hormetic heat shock also reduces the progressive accumulation of PolyQ aggregates in an autophagy-dependent manner. These findings demonstrate that autophagy contributes to stress resistance and hormesis, and reveal a requirement for autophagy in HSF-1-regulated functions in the heat-shock response, proteostasis and ageing.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 28198373 · DOI · PMC5316864

Lithium Promotes Longevity through GSK3/NRF2-Dependent Hormesis [2]

Research article Castillo-Quan JI, Li L, Kinghorn KJ, Ivanov DK, Tain LS, Slack C, et al. · · 2016 · cited 160 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
The quest to extend healthspan via pharmacological means is becoming increasingly urgent, both from a health and economic perspective.
Closing excerpt
The discovery of GSK-3 as a therapeutic target for aging will likely lead to more effective treatments that can modulate mammalian aging and further improve health in later life.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (137 words)

The quest to extend healthspan via pharmacological means is becoming increasingly urgent, both from a health and economic perspective. Here we show that lithium, a drug approved for human use, promotes longevity and healthspan. We demonstrate that lithium extends lifespan in female and male Drosophila, when administered throughout adulthood or only later in life. The life-extending mechanism involves the inhibition of glycogen synthase kinase-3 (GSK-3) and activation of the transcription factor nuclear factor erythroid 2-related factor (NRF-2). Combining genetic loss of the NRF-2 repressor Kelch-like ECH-associated protein 1 (Keap1) with lithium treatment revealed that high levels of NRF-2 activation conferred stress resistance, while low levels additionally promoted longevity. The discovery of GSK-3 as a therapeutic target for aging will likely lead to more effective treatments that can modulate mammalian aging and further improve health in later life.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 27068460 · DOI · PMC4850359

Hormesis: Path and Progression to Significance [3]

Review article Calabrese EJ · · 2018 · cited 158 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
This paper tells the story of how hormesis became recognized as a fundamental concept in biology, affecting toxicology, microbiology, medicine, public health, agriculture, and all areas related to enhancing biological performance.
Closing excerpt
This paper also explains the application of hormesis to several neurodegenerative diseases such as Parkinson's and Huntington's disease, macrophage polarization and its systematic adaptive protections, and the role of hormesis in enhancing stem cell functioning and medical applications.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (102 words)

This paper tells the story of how hormesis became recognized as a fundamental concept in biology, affecting toxicology, microbiology, medicine, public health, agriculture, and all areas related to enhancing biological performance. This paper assesses how hormesis enhances resilience to normal aging and protects against a broad spectrum of neurodegenerative, cardiovascular, and other diseases, as well as trauma and other threats to health and well-being. This paper also explains the application of hormesis to several neurodegenerative diseases such as Parkinson's and Huntington's disease, macrophage polarization and its systematic adaptive protections, and the role of hormesis in enhancing stem cell functioning and medical applications.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 30248927 · DOI · PMC6213774

Moderate nutritional stress reprogrammes insulin responses to drive enhanced starvation tolerance in Drosophila melanogaster [4]

Research article Menon RV, Varghese J · · 2026 · cited 3 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Organisms in the wild constantly encounter fluctuations in temperature and food availability, pathogens and other stressors that disrupt their physiological balance.
Closing excerpt
These insights will improve our understanding of the molecular and metabolic mechanisms driving hormesis, with broader implications for stress resilience and organismal health.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (210 words)

Organisms in the wild constantly encounter fluctuations in temperature and food availability, pathogens and other stressors that disrupt their physiological balance. To counteract these disruptions, organisms initiate stress responses that vary in nature depending on the intensity and duration of the stressor. While severe stress can be harmful or even fatal, moderate stress can activate adaptive mechanisms, a phenomenon known as hormesis. Hormesis enhances resilience to stress and has been associated with improved ageing, immunity and metabolism. Short-term exposures to mild stress, such as heat or oxidative stress, have been shown to extend Drosophila lifespan and promote cross-tolerance to other stressors. Among various environmental stressors, starvation poses a significant and recurring challenge that has driven the evolution of energy-conserving strategies essential for survival. Prior exposure to starvation has been shown to influence longevity, resilience to starvation, physiological status and stress tolerance. However, the mechanisms underlying these hormetic effects remain poorly understood. In this study, we investigated how short-term starvation enhances resistance to prolonged food deprivation in Drosophila. Our findings reveal that metabolic rewiring, including changes in energy utilization, insulin signalling and transcriptomic profiles, underpins this adaptive plasticity. These insights will improve our understanding of the molecular and metabolic mechanisms driving hormesis, with broader implications for stress resilience and organismal health.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41378461 · DOI · PMC12891944

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Hormetic mechanisms [5]
    Calabrese EJ · Crit Rev Toxicol · 2013 · cited 300 times (Europe PMC)
  • Research article Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity [6]
    Calabrese V, Cornelius C, Dinkova-Kostova AT, Iavicoli I, Di Paola R, Koverech A, et al. · Biochim Biophys Acta · 2012 · cited 289 times (Europe PMC)
  • Research article Insecticide-induced hormesis and arthropod pest management [7]
    Guedes RN, Cutler GC · Pest Manag Sci · 2014 · cited 214 times (Europe PMC)
  • Research article Preconditioning is hormesis part I: Documentation, dose-response features and mechanistic foundations [8]
    Calabrese EJ · Pharmacol Res · 2016 · cited 168 times (Europe PMC)
  • Research article Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity [9]
    Calabrese V, Cornelius C, Cuzzocrea S, Iavicoli I, Rizzarelli E, Calabrese EJ · Mol Aspects Med · 2011 · cited 166 times (Europe PMC)
  • Research article Preconditioning is hormesis part II: How the conditioning dose mediates protection: Dose optimization within temporal and mechanistic frameworks [10]
    Calabrese EJ · Pharmacol Res · 2016 · cited 160 times (Europe PMC)

References

  1. Kumsta C, Chang JT, Schmalz J, Hansen M. Hormetic heat stress and HSF-1 induce autophagy to improve survival and proteostasis in C. elegans. . 2017. PMID 28198373 · DOI · PMC5316864
  2. Castillo-Quan JI, Li L, Kinghorn KJ, Ivanov DK, Tain LS, Slack C, et al.. Lithium Promotes Longevity through GSK3/NRF2-Dependent Hormesis. . 2016. PMID 27068460 · DOI · PMC4850359
  3. Calabrese EJ. Hormesis: Path and Progression to Significance. . 2018. PMID 30248927 · DOI · PMC6213774
  4. Menon RV, Varghese J. Moderate nutritional stress reprogrammes insulin responses to drive enhanced starvation tolerance in Drosophila melanogaster. . 2026. PMID 41378461 · DOI · PMC12891944
  5. Calabrese EJ. Hormetic mechanisms. Crit Rev Toxicol. 2013. PMID 23875765 · DOI
  6. Calabrese V, Cornelius C, Dinkova-Kostova AT, Iavicoli I, Di Paola R, Koverech A, et al.. Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity. Biochim Biophys Acta. 2012. PMID 22108204 · DOI
  7. Guedes RN, Cutler GC. Insecticide-induced hormesis and arthropod pest management. Pest Manag Sci. 2014. PMID 24155227 · DOI
  8. Calabrese EJ. Preconditioning is hormesis part I: Documentation, dose-response features and mechanistic foundations. Pharmacol Res. 2016. PMID 26757428 · DOI
  9. Calabrese V, Cornelius C, Cuzzocrea S, Iavicoli I, Rizzarelli E, Calabrese EJ. Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity. Mol Aspects Med. 2011. PMID 22020114 · DOI
  10. Calabrese EJ. Preconditioning is hormesis part II: How the conditioning dose mediates protection: Dose optimization within temporal and mechanistic frameworks. Pharmacol Res. 2016. PMID 26748033 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-29.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Maximum Tolerated DosePharmacology
  • Drug TolerancePharmacology
  • Down-RegulationPharmacology
  • Drug InteractionsPharmacology
  • Drug ResistancePharmacology
  • Insulin ResistancePharmacology

All 99 articles in Pharmacology →

At a glance

962
PubMed records on this heading
49%
published since 2020
296
review articles
2
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-29; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Maximum Tolerated DosePharmacology
  • Drug TolerancePharmacology
  • Down-RegulationPharmacology
  • Drug InteractionsPharmacology
  • Drug ResistancePharmacology

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support